Radiofrequency catheter ablation and nerve growth factor concentration in humans
Background
In animal models, expression of nerve growth factor (NGF) is increased after necrotic myocardial injury. Whether radiofrequency (RF) catheter ablation increases NGF expression in humans is unclear.
Objectives
The purpose of this study was to determine NGF concentrations in the aorta, coronary sinus, and peripheral veins before and after RF ablation in patients.
Methods
We sampled blood from aorta and either great cardiac vein (group 1, N = 18) or proximal (group 2, N = 20) coronary sinus before and after RF ablation. In group 3 (N = 21), peripheral venous blood was sampled before and after RF ablation and then up to postoperative day 7. In group 4 (N = 10), we sampled peripheral venous blood during diagnostic electrophysiologic study. The NGF concentration was determined by enzyme-linked immunosorbent assay. Transcardiac NGF concentration was the difference in NGF concentrations between coronary sinus and aorta.
Results
There was no change in transcardiac NGF concentrations in groups 1 and 2. In group 3, the NGF level did not change significantly from before the procedure (17.10 ± 15.80 ng/mL) to immediately after the procedure (14.46 ± 10.36 ng/mL). However, NGF levels increased significantly to 31.24 ± 19.82 ng/mL (N = 21, P <.0001) on postoperative day 1, 26.23 ± 16.89 ng/mL (N = 20, P <.001) on postoperative day 2, and 22.01 ± 11.35 ng/mL (N = 16, P = .003) on postoperative day 3. NGF concentrations did not change significantly in group 4.
Conclusion
RF ablation did not result in a detectable increase of transcardiac NGF concentration immediately after the procedure. However, the systemic NGF concentration increased significantly on postoperative days 1 to 3, suggesting that RF ablation resulted in increased NGF expression.
Keywords: Atrial fibrillation , Enzyme-linked immunosorbent assay , Nerve growth factor , Neurotrophic factor
To access this article, please choose from the options below
This study was supported by National Institutes of Health Grants HL66389, HL78932, P50-HL52319, and HL71140; a Wasserman Foundation Endowment; and a Pauline and Harold Price Endowment.
PII: S1547-5271(06)01729-2
doi:10.1016/j.hrthm.2006.06.033
© 2006 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
